NEJM:孕期癫痫发作率及抗癫痫药物剂量调整

2020-12-26MedSci原创MedSci原创

对于癫痫女性患者,孕期癫痫发作率高于围产期,但其绝对风险与一般女性患者相当,而怀孕期间,抗癫痫药物剂量的调整可能是导致发病率较高的主要因素

女性 癫痫患者妊娠期治疗需要在维持疾病稳定控制和药物对胎儿的潜在不良影响之间取得平衡。癫痫抽搐对母婴都是危险的,可导致钝性创伤和低氧血症。有研究报告称,癫痫孕妇的产妇死亡率较高,其中多达79%的癫痫相关死亡是由于突然意外造成的。但由于缺少相应的对照组,怀孕对癫痫女性发作频率变化的研究尚不充分。近日研究人员开展前瞻性、观察性、多中心队列研究,比较了癫痫产妇围产期(产后6周内)与孕期(孕7.5个月之前)癫痫发病率的变化。
围产期产妇癫痫发病数据为第一集合,孕期癫痫发病数据为第二集合,以患有癫痫的非孕妇为对照组,同样进行18个月的随访,记录其癫痫发病情况。研究的主要终点为癫痫发病率,次要终点为抗癫痫药物剂量变化。
351名孕妇及109名对照癫痫女性患者参与研究,研究期间299名孕妇和109名对照组女性患者癫痫发作,其中仅70名(23%)产妇在围产期的癫痫发作频率高于孕期,而对照组23名患者在相同时间内癫痫发作(25%)。孕期,74%的产妇调整了抗癫痫药物的剂量,而对照组期间仅31%的患者调整了剂量。
孕期与围产期癫痫发病率及药物调整情况
研究认为,对于癫痫女性患者,孕期癫痫发作率高于围产期,但其绝对风险与一般女性患者相当,而怀孕期间,患者抗癫痫药物剂量调整率较高。
原始出处:
Page B. Pennell et al. Changes in Seizure Frequency and Antiepileptic Therapy during Pregnancy.N Engl J Med, December 24, 2020.

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区(7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1716061, encodeId=630c1e16061ee, content=#抗癫痫#, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55557, encryptionId=a4175555e85, topicName=抗癫痫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=695a32117432, createdName=shuangle, createdTime=Sat Jan 16 09:52:54 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1945102, encodeId=5ef81945102c0, content=#药物剂量#, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87690, encryptionId=19068e690ab, topicName=药物剂量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Tue Nov 30 06:52:54 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1414716, encodeId=1b1d1414e168c, content=#抗癫痫药物#, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55559, encryptionId=94a85555919, topicName=抗癫痫药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ca3082114, createdName=mgqwxj, createdTime=Mon Dec 28 03:52:54 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911467, encodeId=f07e91146e32, content=很好的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/95ac6d022b194200b46211c8dd67d7d4/d7639abce33d42f18edacbf9c1818b2b.jpg, createdBy=1c242248512, createdName=医路顺丰, createdTime=Sun Dec 27 22:44:16 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911174, encodeId=38669111e4d6, content=#心血管#学习了,很好的文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/95ac6d022b194200b46211c8dd67d7d4/d7639abce33d42f18edacbf9c1818b2b.jpg, createdBy=1c242248512, createdName=医路顺丰, createdTime=Sat Dec 26 23:45:31 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035537, encodeId=c8a9103553e35, content=顶刊就是顶刊,谢谢williamhill asia 带来这么高水平的研究报道,williamhill asia 科里同事经常看williamhill asia ,分享williamhill asia 上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Dec 26 15:52:54 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911082, encodeId=4cff91108241, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/19A78ACCA514A62ED89322FF8BE440FD/100, createdBy=3fd82549592, createdName=一叶,一菩提, createdTime=Sat Dec 26 13:47:37 CST 2020, time=2020-12-26, status=1, ipAttribution=)]
    2021-01-16 shuangle
  2. [GetPortalCommentsPageByObjectIdResponse(id=1716061, encodeId=630c1e16061ee, content=#抗癫痫#, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55557, encryptionId=a4175555e85, topicName=抗癫痫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=695a32117432, createdName=shuangle, createdTime=Sat Jan 16 09:52:54 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1945102, encodeId=5ef81945102c0, content=#药物剂量#, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87690, encryptionId=19068e690ab, topicName=药物剂量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Tue Nov 30 06:52:54 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1414716, encodeId=1b1d1414e168c, content=#抗癫痫药物#, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55559, encryptionId=94a85555919, topicName=抗癫痫药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ca3082114, createdName=mgqwxj, createdTime=Mon Dec 28 03:52:54 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911467, encodeId=f07e91146e32, content=很好的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/95ac6d022b194200b46211c8dd67d7d4/d7639abce33d42f18edacbf9c1818b2b.jpg, createdBy=1c242248512, createdName=医路顺丰, createdTime=Sun Dec 27 22:44:16 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911174, encodeId=38669111e4d6, content=#心血管#学习了,很好的文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/95ac6d022b194200b46211c8dd67d7d4/d7639abce33d42f18edacbf9c1818b2b.jpg, createdBy=1c242248512, createdName=医路顺丰, createdTime=Sat Dec 26 23:45:31 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035537, encodeId=c8a9103553e35, content=顶刊就是顶刊,谢谢williamhill asia 带来这么高水平的研究报道,williamhill asia 科里同事经常看williamhill asia ,分享williamhill asia 上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Dec 26 15:52:54 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911082, encodeId=4cff91108241, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/19A78ACCA514A62ED89322FF8BE440FD/100, createdBy=3fd82549592, createdName=一叶,一菩提, createdTime=Sat Dec 26 13:47:37 CST 2020, time=2020-12-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1716061, encodeId=630c1e16061ee, content=#抗癫痫#, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55557, encryptionId=a4175555e85, topicName=抗癫痫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=695a32117432, createdName=shuangle, createdTime=Sat Jan 16 09:52:54 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1945102, encodeId=5ef81945102c0, content=#药物剂量#, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87690, encryptionId=19068e690ab, topicName=药物剂量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Tue Nov 30 06:52:54 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1414716, encodeId=1b1d1414e168c, content=#抗癫痫药物#, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55559, encryptionId=94a85555919, topicName=抗癫痫药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ca3082114, createdName=mgqwxj, createdTime=Mon Dec 28 03:52:54 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911467, encodeId=f07e91146e32, content=很好的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/95ac6d022b194200b46211c8dd67d7d4/d7639abce33d42f18edacbf9c1818b2b.jpg, createdBy=1c242248512, createdName=医路顺丰, createdTime=Sun Dec 27 22:44:16 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911174, encodeId=38669111e4d6, content=#心血管#学习了,很好的文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/95ac6d022b194200b46211c8dd67d7d4/d7639abce33d42f18edacbf9c1818b2b.jpg, createdBy=1c242248512, createdName=医路顺丰, createdTime=Sat Dec 26 23:45:31 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035537, encodeId=c8a9103553e35, content=顶刊就是顶刊,谢谢williamhill asia 带来这么高水平的研究报道,williamhill asia 科里同事经常看williamhill asia ,分享williamhill asia 上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Dec 26 15:52:54 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911082, encodeId=4cff91108241, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/19A78ACCA514A62ED89322FF8BE440FD/100, createdBy=3fd82549592, createdName=一叶,一菩提, createdTime=Sat Dec 26 13:47:37 CST 2020, time=2020-12-26, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1716061, encodeId=630c1e16061ee, content=#抗癫痫#, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55557, encryptionId=a4175555e85, topicName=抗癫痫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=695a32117432, createdName=shuangle, createdTime=Sat Jan 16 09:52:54 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1945102, encodeId=5ef81945102c0, content=#药物剂量#, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87690, encryptionId=19068e690ab, topicName=药物剂量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Tue Nov 30 06:52:54 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1414716, encodeId=1b1d1414e168c, content=#抗癫痫药物#, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55559, encryptionId=94a85555919, topicName=抗癫痫药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ca3082114, createdName=mgqwxj, createdTime=Mon Dec 28 03:52:54 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911467, encodeId=f07e91146e32, content=很好的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/95ac6d022b194200b46211c8dd67d7d4/d7639abce33d42f18edacbf9c1818b2b.jpg, createdBy=1c242248512, createdName=医路顺丰, createdTime=Sun Dec 27 22:44:16 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911174, encodeId=38669111e4d6, content=#心血管#学习了,很好的文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/95ac6d022b194200b46211c8dd67d7d4/d7639abce33d42f18edacbf9c1818b2b.jpg, createdBy=1c242248512, createdName=医路顺丰, createdTime=Sat Dec 26 23:45:31 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035537, encodeId=c8a9103553e35, content=顶刊就是顶刊,谢谢williamhill asia 带来这么高水平的研究报道,williamhill asia 科里同事经常看williamhill asia ,分享williamhill asia 上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Dec 26 15:52:54 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911082, encodeId=4cff91108241, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/19A78ACCA514A62ED89322FF8BE440FD/100, createdBy=3fd82549592, createdName=一叶,一菩提, createdTime=Sat Dec 26 13:47:37 CST 2020, time=2020-12-26, status=1, ipAttribution=)]
    2020-12-27 医路顺丰

    很好的文章,学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1716061, encodeId=630c1e16061ee, content=#抗癫痫#, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55557, encryptionId=a4175555e85, topicName=抗癫痫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=695a32117432, createdName=shuangle, createdTime=Sat Jan 16 09:52:54 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1945102, encodeId=5ef81945102c0, content=#药物剂量#, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87690, encryptionId=19068e690ab, topicName=药物剂量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Tue Nov 30 06:52:54 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1414716, encodeId=1b1d1414e168c, content=#抗癫痫药物#, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55559, encryptionId=94a85555919, topicName=抗癫痫药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ca3082114, createdName=mgqwxj, createdTime=Mon Dec 28 03:52:54 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911467, encodeId=f07e91146e32, content=很好的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/95ac6d022b194200b46211c8dd67d7d4/d7639abce33d42f18edacbf9c1818b2b.jpg, createdBy=1c242248512, createdName=医路顺丰, createdTime=Sun Dec 27 22:44:16 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911174, encodeId=38669111e4d6, content=#心血管#学习了,很好的文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/95ac6d022b194200b46211c8dd67d7d4/d7639abce33d42f18edacbf9c1818b2b.jpg, createdBy=1c242248512, createdName=医路顺丰, createdTime=Sat Dec 26 23:45:31 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035537, encodeId=c8a9103553e35, content=顶刊就是顶刊,谢谢williamhill asia 带来这么高水平的研究报道,williamhill asia 科里同事经常看williamhill asia ,分享williamhill asia 上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Dec 26 15:52:54 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911082, encodeId=4cff91108241, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/19A78ACCA514A62ED89322FF8BE440FD/100, createdBy=3fd82549592, createdName=一叶,一菩提, createdTime=Sat Dec 26 13:47:37 CST 2020, time=2020-12-26, status=1, ipAttribution=)]
    2020-12-26 医路顺丰

    #心血管#学习了,很好的文章!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1716061, encodeId=630c1e16061ee, content=#抗癫痫#, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55557, encryptionId=a4175555e85, topicName=抗癫痫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=695a32117432, createdName=shuangle, createdTime=Sat Jan 16 09:52:54 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1945102, encodeId=5ef81945102c0, content=#药物剂量#, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87690, encryptionId=19068e690ab, topicName=药物剂量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Tue Nov 30 06:52:54 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1414716, encodeId=1b1d1414e168c, content=#抗癫痫药物#, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55559, encryptionId=94a85555919, topicName=抗癫痫药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ca3082114, createdName=mgqwxj, createdTime=Mon Dec 28 03:52:54 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911467, encodeId=f07e91146e32, content=很好的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/95ac6d022b194200b46211c8dd67d7d4/d7639abce33d42f18edacbf9c1818b2b.jpg, createdBy=1c242248512, createdName=医路顺丰, createdTime=Sun Dec 27 22:44:16 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911174, encodeId=38669111e4d6, content=#心血管#学习了,很好的文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/95ac6d022b194200b46211c8dd67d7d4/d7639abce33d42f18edacbf9c1818b2b.jpg, createdBy=1c242248512, createdName=医路顺丰, createdTime=Sat Dec 26 23:45:31 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035537, encodeId=c8a9103553e35, content=顶刊就是顶刊,谢谢williamhill asia 带来这么高水平的研究报道,williamhill asia 科里同事经常看williamhill asia ,分享williamhill asia 上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Dec 26 15:52:54 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911082, encodeId=4cff91108241, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/19A78ACCA514A62ED89322FF8BE440FD/100, createdBy=3fd82549592, createdName=一叶,一菩提, createdTime=Sat Dec 26 13:47:37 CST 2020, time=2020-12-26, status=1, ipAttribution=)]
    2020-12-26 旺医

    顶刊就是顶刊,谢谢williamhill asia 带来这么高水平的研究报道,williamhill asia 科里同事经常看williamhill asia ,分享williamhill asia 上的信息

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1716061, encodeId=630c1e16061ee, content=#抗癫痫#, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55557, encryptionId=a4175555e85, topicName=抗癫痫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=695a32117432, createdName=shuangle, createdTime=Sat Jan 16 09:52:54 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1945102, encodeId=5ef81945102c0, content=#药物剂量#, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87690, encryptionId=19068e690ab, topicName=药物剂量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Tue Nov 30 06:52:54 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1414716, encodeId=1b1d1414e168c, content=#抗癫痫药物#, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55559, encryptionId=94a85555919, topicName=抗癫痫药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ca3082114, createdName=mgqwxj, createdTime=Mon Dec 28 03:52:54 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911467, encodeId=f07e91146e32, content=很好的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/95ac6d022b194200b46211c8dd67d7d4/d7639abce33d42f18edacbf9c1818b2b.jpg, createdBy=1c242248512, createdName=医路顺丰, createdTime=Sun Dec 27 22:44:16 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911174, encodeId=38669111e4d6, content=#心血管#学习了,很好的文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/95ac6d022b194200b46211c8dd67d7d4/d7639abce33d42f18edacbf9c1818b2b.jpg, createdBy=1c242248512, createdName=医路顺丰, createdTime=Sat Dec 26 23:45:31 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035537, encodeId=c8a9103553e35, content=顶刊就是顶刊,谢谢williamhill asia 带来这么高水平的研究报道,williamhill asia 科里同事经常看williamhill asia ,分享williamhill asia 上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Dec 26 15:52:54 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911082, encodeId=4cff91108241, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/19A78ACCA514A62ED89322FF8BE440FD/100, createdBy=3fd82549592, createdName=一叶,一菩提, createdTime=Sat Dec 26 13:47:37 CST 2020, time=2020-12-26, status=1, ipAttribution=)]
    2020-12-26 一叶,一菩提

    学到了

    0

相关威廉亚洲官网

Nat Commun:癫痫相关神经元亚型的鉴定以及癫痫发生的相关潜在表达基因分析

癫痫病是一种神经系统疾病,其特征为自发性发作和反复发作,主要发生在海马体或大脑皮层区域。目前癫痫病仍然是最常见的严重慢性大脑疾病,全球超过6800万人受到该病的影响。活动性癫痫是一种破坏性的疾病,患者

Neurology:癫痫和痴呆之间的双向关联

癫痫和痴呆之间存在双向关联,与对照者相比,这两种疾病患者发生另一种疾病的风险接近2倍。

Nat Commun :迄今为止很大的单细胞数据集!为找到癫痫影响的基因,研究人员分析了超11万神经元

癫痫症是一种神经系统疾病,也是最常见的严重慢性大脑疾病,其特征是自发性发作和反复发作,主要发生在海马或大脑皮层区域。目前,全世界已有超过6800万人受到癫痫症的影响。

JNNP:扩展MOG抗体相关疾病(MOGAD)的表型:半个世纪的癫痫和复发性视神经炎

自身免疫性疾病为临床神经学中发现新的表型开辟了一个新的领域。由于自身免疫病理生理学的研究,导致了包括长期免疫抑制在内的成功的治疗策略。髓鞘少突胶质细胞糖蛋白抗体相关疾病(MOGAD)中,中枢神经系统的

JNNP:COVID-19患者癫痫样活动与癫痫发作

急性症状性癫痫在COVID-19患者中的零星病例中有报道。然而,最近一项大型回顾性队列研究表明,这些患者急性症状性癫痫发作的风险没有增加。因此,癫痫发作与COVID-19的关联性尚未确定。癫痫样活动在

JAMA Neurol:Ezogabine对ALS患者皮层和脊髓运动神经元兴奋性的影响

Ezogabine降低了ALS患者的皮层和脊髓运动神经元的兴奋性,提示这种神经生理学指标可以作为临床试验的药效学生物标志物